Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2708 USD | -20.31% | +4.15% | -95.39% |
22/04 | First Amended Joint Reorganization and Disclosure Statement Plan Filed by Cano Health, Inc. | CI |
15/04 | Motion for De Minimis Asset Sale Approved for Cano Health, Inc. | CI |
Sales 2022 | 2.74B 228B | Sales 2023 | 3.14B 262B | Capitalization | 16.79M 1.4B |
---|---|---|---|---|---|
Net income 2022 | -207M -17.26B | Net income 2023 | -594M -49.53B | EV / Sales 2022 | 0.55 x |
Net Debt 2022 | 1.17B 97.75B | Net Debt 2023 | 1.22B 102B | EV / Sales 2023 | 0.39 x |
P/E ratio 2022 |
-1.44
x | P/E ratio 2023 |
-0.02
x | Employees | 2,700 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 62.05% |
Latest transcript on Cano Health, Inc.
1 day | -20.31% | ||
1 week | +4.15% | ||
Current month | +23.09% | ||
1 month | +28.95% | ||
3 months | -89.82% | ||
6 months | -97.95% | ||
Current year | -95.39% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Kent
CEO | Chief Executive Officer | 56 | 05/23/05 |
Eladio Gil
DFI | Director of Finance/CFO | - | - |
Chief Operating Officer | 57 | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patricia Ferrari
BRD | Director/Board Member | 65 | 18/12 |
Director/Board Member | 50 | 01/19/01 | |
Solomon Trujillo
CHM | Chairman | 71 | 01/21/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 237 M€ | +2.89% | - | |
0.01% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.2708 | -20.31% | 6,931 |
25/24/25 | 0.3398 | +21.14% | 16,508 |
24/24/24 | 0.2805 | -19.81% | 16,975 |
23/24/23 | 0.3498 | +39.86% | 28,881 |
22/24/22 | 0.2501 | -3.81% | 9,951 |
Delayed Quote OTC Markets, April 27, 2024 at 01:24 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
-95.39% | 1.28M | |
-20.16% | 16.21B | |
+4.50% | 12.44B | |
+3.98% | 11.58B | |
+9.72% | 10.79B | |
+23.61% | 8.26B | |
-2.19% | 7.68B | |
+20.75% | 7.2B | |
+4.49% | 6.67B | |
+50.89% | 4.66B |
- Stock Market
- Equities
- JWS Stock